Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
Clinical trial NCT00435396 · COMPLETED
Trial details
- NCT number
- NCT00435396
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-22
- Primary completion
- 2008-08-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.